Aidan Fry BA

Aidan Fry is currently working as a director at STADA Group. He had completed his education at the University of Bristol. He specialized in biotechnology. With over 20 years of experience in reporting on the global pharmaceutical industry, Aidan focuses in his role as editor of Generics bulletin, particularly on commercial, regulatory and legal issues affecting the generic, biosimilar, value-added, and OTC medicines industries. This includes in-depth analyses of corporate strategy, legislative changes, legal precedents, and product perspectives. He regularly interviews leading industry executives and moderates prestigious events. Aidan also oversees the Global Generics & Biosimilars Awards. Aidan speaks fluent German and has a particular affection for maps.